Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenfu Xiangshao Decoction is a traditional Chinese medicine (TCM) herbal formula used primarily for the treatment of heart failure and to improve quality of life and activity tolerance in affected patients. It is based on the classical Shenfu decoction, which typically contains Panax ginseng (Asian ginseng) and Aconitum carmichaeli (processed aconite), but "Xiangshao" indicates a modified or extended formulation, though specific additional ingredients are not detailed in available sources. The mechanism of action is believed to involve enhancement of cardiac contractility, improvement of coronary blood supply, protection against myocardial ischemia, reduction of inflammatory mediators such as tumor necrosis factor-α (TNF-α), scavenging free radicals, and modulation of neurohormonal factors like angiotensin converting enzyme (ACE), renin (REN), aldosterone (ALD), atrial natriuretic polypeptide (ANP), among others[1][3][9]. Clinical studies suggest it may improve left ventricular ejection fraction and hepatic function in chronic heart failure patients[1][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shenfu Xiangshao Decoction.